We are live on
!
Find out more
SCA
STALEY CAPITAL ADVISERS Portfolio holdings
AUM
$2.36B
1-Year Est. Return
23.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+23.72%
3 Year Est. Return
+72.54%
5 Year Est. Return
+79.76%
10 Year Est. Return
+284.42%
AUM
$2.17B
AUM Growth
+$31.6M
(+1.5%)
Cap. Flow
-$21.2M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
48.47%
Holding
188
New
5
Increased
37
Reduced
50
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$56.5M |
| 2 |
Pfizer
PFE
|
+$16.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.56M |
| 4 |
Mercury Systems
MRCY
|
+$1.42M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$72.2M |
| 2 |
Qualcomm
QCOM
|
+$5.98M |
| 3 |
NVIDIA
NVDA
|
+$4.85M |
| 4 |
Philip Morris
PM
|
+$2.85M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$2.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Financials | 10.39% |
| 3 | Consumer Discretionary | 8.57% |
| 4 | Communication Services | 7.83% |
| 5 | Industrials | 6.84% |
Similar funds
EC
BJL
HFM
CC
ROIC
CIP
HAG
G
STALEY CAPITAL ADVISERS's Q2 2024 Portfolio in Review
As of Q2 2024, STALEY CAPITAL ADVISERS held 188 positions worth $2.17B, up 1.5% from $2.14B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
STALEY CAPITAL ADVISERS's Q2 2024 filing shows 5 new, 37 increased, 50 reduced and 6 closed positions. Its largest new stake was J.M. Smucker: 499,125 shares worth $54.4M. The largest sale was CVS Health, an estimated $72.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- STALEY CAPITAL ADVISERS's largest Q2 2024 buy was J.M. Smucker: 499,125 shares worth $54.4M.
- STALEY CAPITAL ADVISERS added most to Pfizer in Q2 2024, an estimated $16.3M increase.
- STALEY CAPITAL ADVISERS's biggest Q2 2024 reduction was Qualcomm, cutting an estimated $5.98M.
- STALEY CAPITAL ADVISERS fully exited CVS Health in Q2 2024, selling an estimated $72.2M.
- STALEY CAPITAL ADVISERS's ten largest holdings make up 48% of its $2.17B portfolio in Q2 2024.
- STALEY CAPITAL ADVISERS opened 5 new positions and closed 6 in Q2 2024.
- STALEY CAPITAL ADVISERS's portfolio value rose 1.5% quarter-over-quarter to $2.17B.
Based on STALEY CAPITAL ADVISERS's 13F filing for Q2 2024, filed 13 Aug 2024.